Related references
Note: Only part of the references are listed.Mild hyperuricemia and subclinical renal damage in untreated primary hypertension
Francesca Viazzi et al.
AMERICAN JOURNAL OF HYPERTENSION (2007)
Telmisartan/hydrochlorothiazide versus valsartan/hydrochlorothiazide in obese hypertensive patients with type 2 diabetes:: the SMOOTH study
Arya M. Sharma et al.
CARDIOVASCULAR DIABETOLOGY (2007)
Concentration-dependent mode of interaction of angiotensin II receptor blockers with uric acid transporter
Takashi Iwanaga et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Telmisartan - A review of its use in the management of hypertension
AJ Battershill et al.
DRUGS (2006)
Molecular-specific effects of angiotensin II antagonists: clinical relevance to treating hypertension?
JL Reid
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2005)
Safety of telmisartan in patients with arterial hypertension - An open-label observational study
MC Michel et al.
DRUG SAFETY (2004)
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
MA Pfeffer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAL randomised trial
K Dickstein et al.
LANCET (2002)
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
JN Cohn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Inhibitory effect of telmisartan on the blood pressure response to angiotensin II challenge
J Stangier et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2001)
Telmisartan - A review of its use in hypertension
M Sharpe et al.
DRUGS (2001)
Pharmacokinetics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients
J Stangier et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2000)
Share Paper
